UnitedHealth, Amedisys have slim chance of getting DOJ challenge dismissed

UnitedHealth Group and Amedisys will likely still have to defend their proposed $3.3 billion merger in court — despite recent efforts to get the DOJ's challenge dismissed.

Why it matters: The outcome of the saga will set the tone for antitrust oversight in health care.